BRIVIACT 10 mg/ml solution orale fl 300 ml

7680658320021 CH-65832 N03AX23 01.07.1.

Reimbursement limitations:

BRIVIACT

En association dans le traitement des crises partielles avec ou sans généralisation secondaire chez l'adulte …

BRIVIACT 10 mg/ml solution orale fl 300 ml
BRIVIACT 10 mg/ml solution orale fl 300 ml
BRIVIACT 10 mg/ml solution orale fl 300 ml
1 / 3
google

Details

Product number
6583201
CPT
-
Packaging group
300
Unit
ml
Composition
brivaracetamum 50 mg, acidum citricum, natrii citras dihydricus, carmellosum natricum, sucralosum, sorbitolum 839.5 mg, glycerolum, aromatica, aqua purificata, E 218 5 mg ad solutionem pro 5 ml corresp. natrium 5.8 mg.

Articles (1)

Briviact 10 mg/ml, solution buvable
Lösung
300
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
839.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HNIDK
(N/A)
5.0 MG Substance HBESI
(N/A)
5.8 MG Substance HBESI

Reimbursement information

Public price
CHF 144.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2017

Authorization holder

UCB-Pharma SA

1630 Bulle

Authorization information

Swissmedic authorization number
65832
Drug name
Briviact, solution buvable
Galenic form
LSOR
ATC Code
N03AX23
Authorization status
Z
Dispensation category
B
First authorization
06/10/2016
Authorization expiration date
31/12/9999
IT number
01.07.1.
Domain
Human medicine

Packaging details

Description (FR)
BRIVIACT 10 mg/ml solution orale fl 300 ml
Description (DE)
BRIVIACT 10 mg/ml Lösung zum Einnehmen Fl 300 ml
Market launch
06/10/2016
Narcotic (BTM)
No

Other packaging sizes